{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:20:32Z","timestamp":1788837632820,"version":"build-2803163510"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA278923"],"award-info":[{"award-number":["U01CA278923"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCI Pancreatic Cancer Detection Consortium","award":["U01CA278923"],"award-info":[{"award-number":["U01CA278923"]}]},{"name":"Clinical and Translational Science Award","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Surveillance of at-risk populations for pancreatic ductal adenocarcinoma (PDAC) is a potential strategy to reduce its incidence and improve its prognosis. However, there is considerable debate about who should participate and relatively little information about how people perceive different testing options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the Health Belief Model as a framework, this qualitative, observational study including eleven focus groups and seven interviews, summarizes the knowledge, motivations, barriers and preferences for PDAC surveillance in underserved populations with low cancer screening rates and for high-risk individuals (HRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HRIs have a high motivation to participate in PDAC screening and perceive few barriers to engage. Participants from underserved populations had little knowledge of PDAC and surveillance, but they were interested in surveillance for PDAC based on their perception of the benefits of cancer screenings. The main barriers for participation in PDAC surveillance programs were cost, distrust of the larger medical system, discomfort associated with the testing, lack of a provider\u2019s recommendation, and fear of a positive result. These barriers varied based on a person\u2019s race\/ethnicity and geographic location (urban vs. rural). Preferences expressed by underserved populations suggest that tests for early PDAC detection will need to be accurate, no or low cost, minimally invasive, and convenient to access. There was a correlation between a person\u2019s self-perceived susceptibility for PDAC and their willingness to tolerate more invasive and less convenient methods. In addition, participants were motivated to participate in early detection programs with clear guidelines accompanied by their doctor\u2019s recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There appears to be an association between actual and perceived risk of PDAC and patient willingness to participate in an early detection program. For populations lower along the risk spectrum, there is limited knowledge about pancreatic cancer or its risk factors, and potentially significant barriers to participate in an early detection program if deemed eligible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748261468819","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:29:44Z","timestamp":1783952984000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Surveillance for Pancreatic Cancer: Knowledge, Motivations, Barriers, and Preferences Among High-Risk Individuals and Underserved Populations"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6856-4406","authenticated-orcid":false,"given":"Emily Van","family":"Houweling","sequence":"first","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"McCoy","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Guimaraes","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Sears","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackilen","family":"Shannon","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige E.","family":"Farris","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Mandrup","family":"J\u00e4derholm","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Cot\u00e9","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University (OHSU)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"1","key":"e_1_3_7_2_2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel RL","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Cancer statistics. 2025;75(1):10-45.","journal-title":"Cancer statistics"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323611"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.02.032"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00298"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10232"},{"issue":"3","key":"e_1_3_7_7_2","first-page":"727","article-title":"Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A: 20 Years of Experience in Leiden","volume":"163","author":"Klatte DCF","year":"2022","unstructured":"Klatte DCF, Boekestijn BKB. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A: 20 Years of Experience in Leiden. Gastroenterology. 2022;163(3):727-738.","journal-title":"Gastroenterology"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1930"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010086"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.023"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.02.001"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.435"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319352"},{"key":"e_1_3_7_14_2","unstructured":"NCCN. Genetic\/FAmilial High-Risk Assessment: Breast Ovarian Pancreatic and Prostate. 2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf?utm_source=openevidence"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191942"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-008-9205-9"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1897-4287-10-8"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-019-00143-7"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-023-01030-5"},{"key":"e_1_3_7_20_2","volume-title":"Oregon Comprehensive Cancer Plan","author":"OHSU","year":"2025","unstructured":"OHSU, OHA. Oregon Comprehensive Cancer Plan. OHSU; 2025."},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2024.9"},{"key":"e_1_3_7_22_2","volume-title":"Handbook of qualitative data analysis","author":"Cornish F","year":"2013","unstructured":"Cornish F, Gillespie A, Zittoun T. Collaborative analysis of qualitative data. In: Handbook of qualitative data analysis, Sage. 2013."},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0574-8"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_3_7_25_2","first-page":"45","article-title":"The health belief model","volume":"4","author":"Champion VL","year":"2008","unstructured":"Champion VL, Skinner CS. The health belief model. Health behavior and health education: Theory, research, and practice. 2008;4:45-65.","journal-title":"Health behavior and health education: Theory, research, and practice"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/15313204.2020.1730285"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","unstructured":"Mukherjee S Antony A Patnam NG et al. Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability. Gut. Published online April 22 2026. doi:10.1136\/gutjnl-2025-337266.","DOI":"10.1136\/gutjnl-2025-337266"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2026.0372"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000430"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000747"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000001352"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261468819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748261468819","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261468819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:47:42Z","timestamp":1784184462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748261468819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["10.1177\/10732748261468819"],"URL":"https:\/\/doi.org\/10.1177\/10732748261468819","relation":{},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"10732748261468819"}}